A 52-year-old male with HER2-positive metastatic breast cancer is started on trastuzumab. Which is the most common serious adverse effect requiring cardiac monitoring during therapy?
See the options, answer & explanation
Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.
